Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novabay Pharmaceuticals
(NY:
NBY
)
0.5287
+0.0249 (+4.94%)
Official Closing Price
Updated: 8:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novabay Pharmaceuticals
< Previous
1
2
3
4
5
6
7
8
Next >
12 Health Care Stocks Moving In Wednesday's After-Market Session
May 22, 2024
Via
Benzinga
Why James Hardie Industries Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 21, 2024
Via
Benzinga
Why Larimar Therapeutics Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
May 21, 2024
Via
Benzinga
NovaBay Pharmaceuticals: Q4 Earnings Insights
March 26, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
May 21, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
May 21, 2024
Pre-market stock movers are worth checking out as we have all of the hottest market news available on Tuesday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
May 20, 2024
Via
Benzinga
NovaBay Pharmaceuticals Stock Is Up 50%: What's Going On?
May 20, 2024
NovaBay Pharmaceuticals shares are trading higher by 50% Monday afternoon. The marked move higher comes despite a lack of company-specific news for the session.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
May 20, 2024
Via
Benzinga
Why Cracker Barrel Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 17, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
May 17, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 17, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
May 17, 2024
The final day of trading this week is here and we have the biggest pre-market stock movers worth watching on Friday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 16, 2024
Via
Benzinga
NovaBay Pharmaceuticals Launches Avenova Product Bundles for Individualized Relief from Multifactorial Dry Eye Symptoms
May 13, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 13, 2024
Via
Benzinga
NBY Stock Earnings: NovaBay Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024
May 09, 2024
NBY stock results show that NovaBay Pharmaceuticals beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results
May 09, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
May 07, 2024
Via
Benzinga
NovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through Amazon
May 07, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024
May 03, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales
April 22, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity
April 19, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses
April 17, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NBY Stock Earnings: NovaBay Pharmaceuticals Beats EPS, Beats Revenue for Q4 2023
March 26, 2024
NBY stock results show that NovaBay Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results
March 26, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Earnings Scheduled For March 26, 2024
March 26, 2024
Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million.
Via
Benzinga
NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024
March 25, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023
March 14, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 06, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.